AUTH:"Plumb ID" - Search results

Symptoms Six Weeks After COVID-19 Are Reduced Among US Health Care Personnel Receiving Additional Vaccine Doses During the Omicron Period, December 2021-April 2022.

Mohr NM, Plumb ID, Santos León E, Pinckney M, Harland KK, Krishnadasan A, Hoth KF, Rwamwejo F, Haran JP, Briggs-Hagen M, Kontowicz E, Talan DA, Project PREVENT Network

Open Forum Infect Dis, 11(10):ofae545, 25 Sep 2024

Cited by: 0 articles | PMID: 39416989 | PMCID: PMC11481461

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Combined Protection of Vaccination and Nirmatrelvir-Ritonavir Against Hospitalization in Adults With COVID-19.

Shah MM, Joyce B, Plumb ID, Sahakian S, Feldstein LR, Barkley E, Paccione M, Deckert J, Sandmann D, Hagen MB, Gerhart JL

Clin Infect Dis, 79(1):108-110, 01 Jul 2024

Cited by: 2 articles | PMID: 38411622

Add to export list

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome After SARS-CoV-2 Infection.

Unger ER, Lin JS, Wisk LE, Yu H, L'Hommedieu M, Lavretsky H, Montoy JCC, Gottlieb MA, Rising KL, Gentile NL, Santangelo M, Venkatesh AK, Rodriguez RM, Hill MJ, Geyer RE, Kean ER, Saydah S, McDonald SA, Huebinger R, [...] Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE) Group

JAMA Netw Open, 7(7):e2423555, 01 Jul 2024

Cited by: 0 articles | PMID: 39046739 | PMCID: PMC11270135

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Characteristics of healthcare personnel with SARS-CoV-2 infection: 10 emerging infections program sites in the United States, April 2020-December 2021.

Chea N, Eure T, Alkis Ramirez R, Zlotorzynska M, Blazek GT, Nadle J, Lee J, Czaja CA, Johnston H, Barter D, Kellogg M, Emanuel C, Meek J, Brackney M, Carswell S, Thomas S, Fridkin SK, Wilson LE, Perlmutter R, [...] Grigg CT

Infect Control Hosp Epidemiol, 1-9, 21 May 2024

Cited by: 0 articles | PMID: 38770586 | PMCID: PMC11518671

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Clinical and laboratory characteristics of patients hospitalized with severe COVID-19 in New Orleans, August 2020 to September 2021.

Drouin A, Plumb ID, McCullough M, James Gist J, Liu S, Theberge M, Katz J, Moreida M, Flaherty S, Chatwani B, Briggs Hagen M, Midgley CM, Fusco D

Sci Rep, 14(1):6539, 19 Mar 2024

Cited by: 2 articles | PMID: 38503862 | PMCID: PMC10951213

Add to export list Review

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Sociodemographic and Occupational Characteristics Associated with Early and Continued COVID-19 Vaccine Uptake Among Healthcare Personnel: Monroe County, NY.

Russ S, Myers C, Licherdell E, Bowden A, Chinchilli E, Dahhan R, Van Wijngaarden E, Plumb ID, Dumyati G

Vaccine, 42(10):2585-2591, 12 Mar 2024

Cited by: 1 article | PMID: 38480100

Add to export list

Ethnic and racial differences in self-reported symptoms, health status, activity level, and missed work at 3 and 6 months following SARS-CoV-2 infection.

O'Laughlin KN, Klabbers RE, Ebna Mannan I, Gentile NL, Geyer RE, Zheng Z, Yu H, Li SX, Chan KCG, Spatz ES, Wang RC, L'Hommedieu M, Weinstein RA, Plumb ID, Gottlieb M, Huebinger RM, Hagen M, Elmore JG, Hill MJ, [...] INSPIRE Group

Front Public Health, 11:1324636, 30 Jan 2024

Cited by: 1 article | PMID: 38352132 | PMCID: PMC10861779

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

ClinSeqSer: Clinical and laboratory characteristics of patients hospitalized with severe COVID-19—New Orleans, August 2020–September 2021

Drouin A, Plumb ID, McCullough M, James-Gist J, Liu S, Theberge M, Katz J, Moreida M, Flaherty S, Chatwani B, Briggs-Hagen M, Midgley CM, Fusco D

Research Square, 22 Dec 2023

Cited by: 0 articles | PPR: PPR778008

Add to export list Preprint v1

Factors associated with the decision to receive bivalent COVID-19 booster vaccination among health care personnel.

Mohr NM, Plumb ID, Santos León E, Harland KK, Krishnadasan A, Nandi U, Hoth KF, Smithline HA, Talan DA

Hum Vaccin Immunother, 19(3):2284471, 23 Nov 2023

Cited by: 0 articles | PMID: 37994545 | PMCID: PMC10760319

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Healthcare providers' knowledge and clinical practice surrounding shigellosis - DocStyles Survey, 2020.

Haston JC, Ford L, Vanden Esschert KL, Plumb ID, Logan N, Francois Watkins LK, Garcia-Williams AG

BMC Prim Care, 24(1):267, 13 Dec 2023

Cited by: 0 articles | PMID: 38087210 | PMCID: PMC10717126

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022-May 2023.

Plumb ID, Briggs Hagen M, Wiegand R, Dumyati G, Myers C, Harland KK, Krishnadasan A, James Gist J, Abedi G, Fleming-Dutra KE, Chea N, Lee JE, Kellogg M, Edmundson A, Britton A, Wilson LE, Lovett SA, Ocampo V, Markus TM, [...] Vaccine Effectiveness among Healthcare Personnel Study Team

Vaccine, 42(10):2543-2552, 14 Nov 2023

Cited by: 4 articles | PMID: 37973512

Add to export list

Effectiveness of a Messenger RNA Vaccine Booster Dose Against Coronavirus Disease 2019 Among US Healthcare Personnel, October 2021-July 2022.

Plumb ID, Mohr NM, Hagen M, Wiegand R, Dumyati G, Harland KK, Krishnadasan A, Gist JJ, Abedi G, Fleming-Dutra KE, Chea N, Lee J, Barter D, Brackney M, Fridkin SK, Wilson LE, Lovett SA, Ocampo V, Phipps EC, [...] Pilishvili T

Open Forum Infect Dis, 10(10):ofad457, 08 Sep 2023

Cited by: 4 articles | PMID: 37799130 | PMCID: PMC10549208

Add to export list Free full text in Europe PMC

Prevalence of Symptoms ≤12 Months After Acute Illness, by COVID-19 Testing Status Among Adults - United States, December 2020-March 2023.

Montoy JCC, Ford J, Yu H, Gottlieb M, Morse D, Santangelo M, O'Laughlin KN, Schaeffer K, Logan P, Rising K, Hill MJ, Wisk LE, Salah W, Idris AH, Huebinger RM, Spatz ES, Rodriguez RM, Klabbers RE, Gatling K, [...] Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE) Group

MMWR Morb Mortal Wkly Rep, 72(32):859-865, 11 Aug 2023

Cited by: 11 articles | PMID: 37561663 | PMCID: PMC10415002

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Antimicrobial-Resistant Nontyphoidal Salmonella Infection Following International Travel-United States, 2018-2019.

Ford L, Shah HJ, Eikmeier D, Hanna S, Chen J, Tagg KA, Langley G, Payne DC, Plumb ID

J Infect Dis, 228(5):533-541, 01 Aug 2023

Cited by: 1 article | PMID: 37129066 | PMCID: PMC10839744

Add to export list Free full text in Europe PMC

Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study.

Gottlieb M, Wang RC, Yu H, Spatz ES, Montoy JCC, Rodriguez RM, Chang AM, Elmore JG, Hannikainen PA, Hill M, Huebinger RM, Idris AH, Lin Z, Koo K, McDonald S, O'Laughlin KN, Plumb ID, Santangelo M, Saydah S, [...] Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE) Group

Clin Infect Dis, 76(11):1930-1941, 01 Jun 2023

Cited by: 38 articles | PMID: 36705268 | PMCID: PMC10249989

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Association Between SARS-CoV-2 Variants and Frequency of Acute Symptoms: Analysis of a Multi-institutional Prospective Cohort Study-December 20, 2020-June 20, 2022.

Wang RC, Gottlieb M, Montoy JCC, Rodriguez RM, Yu H, Spatz ES, Chandler CW, Elmore JG, Hannikainen PA, Chang AM, Hill M, Huebinger RM, Idris AH, Koo K, Li SX, McDonald S, Nichol G, O'Laughlin KN, Plumb ID, [...] Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE) Group

Open Forum Infect Dis, 10(7):ofad275, 23 May 2023

Cited by: 7 articles | PMID: 37426947 | PMCID: PMC10327880

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Trends in Laboratory-Confirmed SARS-CoV-2 Reinfections and Associated Hospitalizations and Deaths Among Adults Aged ≥18 Years - 18 U.S. Jurisdictions, September 2021-December 2022.

Ma KC, Dorabawila V, León TM, Henry H, Johnson AG, Rosenberg E, Mansfield JA, Midgley CM, Plumb ID, Aiken J, Khanani QA, Auche S, Bayoumi NS, Bennett SA, Bernu C, Chang C, Como-Sabetti KJ, Cueto K, Cunningham S, [...] Scobie HM

MMWR Morb Mortal Wkly Rep, 72(25):683-689, 23 Jun 2023

Cited by: 18 articles | PMID: 37347715 | PMCID: PMC10328471

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Long COVID Clinical Phenotypes up to 6 Months After Infection Identified by Latent Class Analysis of Self-Reported Symptoms.

Gottlieb M, Spatz ES, Yu H, Wisk LE, Elmore JG, Gentile NL, Hill M, Huebinger RM, Idris AH, Kean ER, Koo K, Li SX, McDonald S, Montoy JCC, Nichol G, O'Laughlin KN, Plumb ID, Rising KL, Santangelo M, [...] INSPIRE Group

Open Forum Infect Dis, 10(7):ofad277, 31 May 2023

Cited by: 10 articles | PMID: 37426952 | PMCID: PMC10327879

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Effectiveness of the COVID-19 vaccines on preventing symptomatic SARS-CoV-2 infections and hospitalizations in Southwestern Alaska, January-December 2021.

Lefferts B, Bruden D, Plumb ID, Hodges E, Bates E, January G, Bruce MG

Vaccine, 41(23):3544-3549, 01 May 2023

Cited by: 1 article | PMID: 37150620 | PMCID: PMC10150184

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Factors associated with COVID-19 vaccination during June-October 2021: A multi-site prospective study.

Datar RS, Fette LM, Hinkelman AN, Hammershaimb EA, Friedman-Klabanoff DJ, Mongraw-Chaffin M, Weintraub WS, Ahmed N, Gibbs MA, Runyon MS, Plumb ID, Thompson W, Saydah S, Edelstein SL, Berry AA, COVID-19 Community Research Partnership

Vaccine, 41(20):3204-3214, 31 Mar 2023

Cited by: 2 articles | PMID: 37069033 | PMCID: PMC10063571

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Three-Month Symptom Profiles Among Symptomatic Adults With Positive and Negative Severe Acute Respiratory Syndrome Coronavirus 2 Tests: A Prospective Cohort Study From the INSPIRE Group.

Spatz ES, Gottlieb M, Wisk LE, Anderson J, Chang AM, Gentile NL, Hill MJ, Huebinger RM, Idris AH, Kinsman J, Koo K, Li SX, McDonald S, Plumb ID, Rodriguez RM, Saydah S, Slovis B, Stephens KA, Unger ER, [...] Venkatesh A

Clin Infect Dis, 76(9):1559-1566, 01 May 2023

Cited by: 11 articles | PMID: 36573005 | PMCID: PMC11361781

Add to export list Free full text in Europe PMC

Use of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Tests by US Infectious Disease Physicians: Results of an Emerging Infections Network Survey, March 2022.

Gundlapalli AV, Beekmann SE, Jones JM, Thornburg NJ, Clarke KEN, Uyeki TM, Satheshkumar PS, Carroll DS, Plumb ID, Briggs-Hagen M, Santibañez S, David-Ferdon C, Polgreen PM, McDonald LC

Open Forum Infect Dis, 10(3):ofad091, 18 Feb 2023

Cited by: 0 articles | PMID: 36949879 | PMCID: PMC10026543

Add to export list Free full text in Europe PMC

Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March-October, 2021.

Plumb ID, Fette LM, Tjaden AH, Feldstein L, Saydah S, Ahmed A, Link-Gelles R, Wierzba TF, Berry AA, Friedman-Klabanoff D, Larsen MP, Runyon MS, Ward LM, Santos RP, Ward J, Weintraub WS, Edelstein S, Uschner D

Vaccine, 41(15):2596-2604, 09 Mar 2023

Cited by: 1 article | PMID: 36932031 | PMCID: PMC9995303

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Point Prevalence Estimates of Activity-Limiting Long-term Symptoms Among United States Adults ≥1 Month After Reported Severe Acute Respiratory Syndrome Coronavirus 2 Infection, 1 November 2021.

Tenforde MW, Devine OJ, Reese HE, Silk BJ, Iuliano AD, Threlkel R, Vu QM, Plumb ID, Cadwell BL, Rose C, Steele MK, Briggs-Hagen M, Ayoubkhani D, Pawelek P, Nafilyan V, Saydah SH, Bertolli J

J Infect Dis, 227(7):855-863, 01 Apr 2023

Cited by: 12 articles | PMID: 35776165 | PMCID: PMC9278232

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Presence of symptoms 6 weeks after COVID-19 among vaccinated and unvaccinated US healthcare personnel: a prospective cohort study.

Mohr NM, Plumb ID, Harland KK, Pilishvili T, Fleming-Dutra KE, Krishnadasan A, Hoth KF, Saydah SH, Mankoff Z, Haran JP, Briggs-Hagen M, León ES, Talan DA, Project PREVENT Network

BMJ Open, 13(2):e063141, 02 Feb 2023

Cited by: 13 articles | PMID: 36731936 | PMCID: PMC9895915

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

Symptoms Six Weeks After COVID-19 Are Reduced Among US Health Care Personnel Receiving Additional Vaccine Doses During the Omicron Period, December 2021-April 2022.

Combined Protection of Vaccination and Nirmatrelvir-Ritonavir Against Hospitalization in Adults With COVID-19.

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome After SARS-CoV-2 Infection.

Characteristics of healthcare personnel with SARS-CoV-2 infection: 10 emerging infections program sites in the United States, April 2020-December 2021.

Clinical and laboratory characteristics of patients hospitalized with severe COVID-19 in New Orleans, August 2020 to September 2021.

Sociodemographic and Occupational Characteristics Associated with Early and Continued COVID-19 Vaccine Uptake Among Healthcare Personnel: Monroe County, NY.

Ethnic and racial differences in self-reported symptoms, health status, activity level, and missed work at 3 and 6 months following SARS-CoV-2 infection.

ClinSeqSer: Clinical and laboratory characteristics of patients hospitalized with severe COVID-19—New Orleans, August 2020–September 2021

Factors associated with the decision to receive bivalent COVID-19 booster vaccination among health care personnel.

Healthcare providers' knowledge and clinical practice surrounding shigellosis - DocStyles Survey, 2020.

Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022-May 2023.

Effectiveness of a Messenger RNA Vaccine Booster Dose Against Coronavirus Disease 2019 Among US Healthcare Personnel, October 2021-July 2022.

Prevalence of Symptoms ≤12 Months After Acute Illness, by COVID-19 Testing Status Among Adults - United States, December 2020-March 2023.

Antimicrobial-Resistant Nontyphoidal Salmonella Infection Following International Travel-United States, 2018-2019.

Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study.

Association Between SARS-CoV-2 Variants and Frequency of Acute Symptoms: Analysis of a Multi-institutional Prospective Cohort Study-December 20, 2020-June 20, 2022.

Trends in Laboratory-Confirmed SARS-CoV-2 Reinfections and Associated Hospitalizations and Deaths Among Adults Aged ≥18 Years - 18 U.S. Jurisdictions, September 2021-December 2022.

Long COVID Clinical Phenotypes up to 6 Months After Infection Identified by Latent Class Analysis of Self-Reported Symptoms.

Effectiveness of the COVID-19 vaccines on preventing symptomatic SARS-CoV-2 infections and hospitalizations in Southwestern Alaska, January-December 2021.

Factors associated with COVID-19 vaccination during June-October 2021: A multi-site prospective study.

Three-Month Symptom Profiles Among Symptomatic Adults With Positive and Negative Severe Acute Respiratory Syndrome Coronavirus 2 Tests: A Prospective Cohort Study From the INSPIRE Group.

Use of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Tests by US Infectious Disease Physicians: Results of an Emerging Infections Network Survey, March 2022.

Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March-October, 2021.

Point Prevalence Estimates of Activity-Limiting Long-term Symptoms Among United States Adults ≥1 Month After Reported Severe Acute Respiratory Syndrome Coronavirus 2 Infection, 1 November 2021.

Presence of symptoms 6 weeks after COVID-19 among vaccinated and unvaccinated US healthcare personnel: a prospective cohort study.

Partnerships & funding